ArticleBriefings in bioinformatics2026
Functional motif detection via in silico ablation using AlphaGenome.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Deciphering which transcription factor (TF) motif instances are functionally required for enhancer activity typically demands ChIP-based assays or labor-intensive perturbation experiments. We introduce a virtual motif-perturbation framework that uses AlphaGenome, a large sequence-to-function foundation model, to infer motif-level regulatory contribution directly from DNA sequence. Candidate C/EBP$\mathrm{\beta} $ motifs are identified within chromatin-active regions and systematically ablated in silico; the resulting changes in predicted regulatory activity are quantified and assessed against a sham-derived null distribution to establish statistical confidence. To evaluate whether sequence-level perturbations recapitulate biologically meaningful regulatory dependence, we compared in silico predictions with CUT&RUN measurements of H3K27ac following CEBPB knockout in multiple myeloma cells. Key activating motifs exhibited concordant loss of H3K27ac across both settings, whereas loci with apparent discrepancies reflected biologically interpretable mechanisms. Together, these findings suggest that large sequence-based models can approximate the directional consequences of TF perturbation, supporting motif-level functional analysis directly from DNA sequence. This supports sequence-only virtual ablation as a scalable framework for hypothesis generation and regulatory annotation that can be extended to additional TFs, cell types, and chromatin modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.